WHAT IS SKYRIZI?

A Different Crohn’s Treatment That Targets a Specific Protein to Help Reduce Damaging Inflammation

SKYRIZI is the first treatment for Crohn’s that works differently by specifically targeting the interleukin-23 (IL-23) protein, which is one of the key proteins responsible for inflammation. By targeting IL-23, SKYRIZI helps reduce the excess inflammation that can contribute to Crohn’s symptoms.

SKYRIZI is a prescription medication for adults with moderate to severe Crohn’s disease. 

Watch this video to learn how SKYRIZI works.

Target and Arrow Icon

Why Does SKYRIZI Target IL-23?

Your body may produce too much of a protein called IL-23. IL-23 is a protein that can contribute to excess inflammation inside the body. When this inflammation doesn’t go away, it can cause Crohn’s disease.

Skyrizi as Protection Icon

This Is Where SKYRIZI Gets to Work

By specifically attaching to the IL-23 protein, SKYRIZI can help reduce the excess inflammation inside the body that can contribute to Crohn’s symptoms.

Is SKYRIZI Right for You?

If your symptoms are continuing to be present, you may need to consider another treatment to manage your Crohn’s. SKYRIZI is a prescription medication that is approved for adults just like you with moderate to severe Crohn’s disease.

Looking for Updates, Answers, and SKYRIZI Support?

Get more information and resources sent directly to you.

Be in the Know With SKYRIZI Info